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Background: Surface electrocardiography (ECG) for assessing the estimated risk for future coronary heart
diseases in the asymptomatic population has not been fully explored. Furthermore, information
regarding age-related differences in such a clinical issue is lacking.
Methods: We evaluated the diagnostic performance of several combinations of voltage criteria obtained
from electrocardiography by comparison to echocardiography performed on 379 individuals without
preexisting cardiovascular diseases and determined the association of these criteria with the Framingham
risk (FRS) and the adult treatment panel (ATP) scores from the National Cholesterol Education Program.
Results: The ECG parameters were signiﬁcantly correlated with the participants’ age. Among participants
< 65 years of age, several criteria (including the Sokolow-Lyon score, Cornell voltage, Cornell product,
McPhie score and Gubner & Ungerleider criteria) were positively associated with FRS by multivariate
analysis, while Cornell voltage, Cornell product, Gubner & Ungerleider criterion and QRS duration were
signiﬁcantly associated with the ATP score. Few ECG criteria were associated with both cardiovascular
risk scores above 65 years of age. However, gender-adjusted McPhie and Gubner & Ungerleider criterion
were observed to be powerful predictors of left ventricular hypertrophy (LVH) in subjects less than 65
years old, as determined by echocardiography.
Conclusion: Electrical alterations, as determined by various parameters from surface ECG, correlate with
age and estimated cardiovascular risk factors, while McPhie and Gubner & Ungerleider criteria help
identify structural changes in terms of LVH in subjects of a relatively younger age.
Copyright  2011, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Much effort has been focused over the decades on developing
tools to assess the risk for coronary heart disease (CHD) in the
asymptomatic population. The Framingham risk score (FRS), which
incorporates risk factors determined during the Framingham Heart
Study, was one of the ﬁrst algorithms developed for this purpose1.erest.
of Cardiology, Department of
Chung-Shan North Road, 2nd
).
iwan Society of Geriatric EmergenThe parameters of the FRS were later extended to include family
history, diabetes, and metabolic syndrome in the adult treatment
panel (ATP) scores developed by the NCEP III2.
A clinical ﬁnding that predicts a high rate of cardiovascular
events is left ventricular hypertrophy (LVH). The physical modiﬁ-
cations associated with LVH can be detected readily by echocardi-
ography3. However, cost and technical considerations have limited
the use of echocardiography for large-scale screening applications4.
Electrocardiology provides information about the electrical prop-
erties of the myocardium5, and ECG parameters have been shown
to be indicators of LVH in patients with hypertension6e8.
Although the various criteria are highly speciﬁc for LVH, they are
limited by low sensitivity. The commonly used ECG abnormalitiescy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
C.-C. Liu et al.156include signs of left atrial abnormality and voltage criteria after
Sokolow-Lyon and Cornell. The sensitivity of ECG in detecting LVH
determined by echocardiography has been reported to be 15% after
Sokolow-Lyon, 15% after McPhie and 31% using all the criteria
combined in a previous study9. However, the relationship between
surface ECG and validated cardiovascular events, when assessed by
FRS or metabolic (ATP) scores, has not been fully elucidated. To
further investigate the use of electrocardiography for screening
populations for assessing future projected cardiovascular diseases,
we examined the diagnostic performance of several new combi-
nations of voltage criteria and their association with the FRS and
ATP scores.
2. Methods
2.1. Study population
Four hundred individuals who underwent general health evalu-
ationswere considered for enrollment during the study period (from
2006 to 2008); however, 21 individuals with known cardiovascular
diseases, which was the only criterion for exclusion, were excluded
from this study. The data for the remaining 379 participants (mean
age¼ 55.611.05 years; proportion of women¼ 41.2%) were
analyzed. Among the 379 participants, the prevalence of hyperten-
sion and diabetes were 13.5% and 6.9%, respectively. Parameters
derived from 12-lead surface ECG, anthropometrics, clinical vari-
ables, medical history, and the results of echocardiography were
recorded. The local institutional ethics board proved this study.
2.2. Measures of cardiovascular risk
Two different estimates of cardiovascular risk were used in the
evaluation: the FRS1 and the ATP score calculated according to
NCEP III2.
2.3. Electrocardiography
Participants underwent routine 12-lead surface electrocardiog-
raphy (ECG) examination with recordings obtained using auto-
nomic instruments (Page Writer Trim III, Philips, Andover, MA,
USA) stored for further analysis. Electrocardiographic criteria
evaluated in this study included: (1) Sokolow-Lyon voltage:
SV1þ RV5 or RV6> 3.5 mV10; (2) gender-adjusted Cornell voltage
criteria: SV3þ RaVL> 2.8 mV for men and> 2.0 mV for women11;
(3) Cornell product: (SV3þ RaVL)QRS duration> 244 mV;
(4) Gubner & Ungerleider criterion: amplitude of R wave in lead
DI minus amplitude of R wave in lead DIII 2.5 mV12; (5) strain
pattern: horizontal or down-sloping ST depression associated with
T wave inversion in lead V5 and or V613; (6) McPhie score:
RV4þ SV1>4.5 mV14 ; and (7) Framingham score: RIþ SIII> 2.5
mV, SV1/2þ RV5/6> 3.5 mV, SV1/2/3> 2.5 mVþ RV4/5/6> 2.5 mV
plus left ventricular strain pattern. Measurement relating to QRS
duration was measured to the nearest 4 milliseconds as possible,
with R-wave amplitudes assessed in leads aVL, V5, V6, and S wave
amplitudes in leads V1 and V3 measured to the nearest 0.5 mm
(0.05 mV) by use of calipers.
2.4. Echocardiography
Transthoracic echocardiography was performed by a single
experienced technician using a Hewlett Packard instrument (Sonos
5500 series) equipped with a 2.5e4.5 MHz transducer. Parameters
including left atrium (LA) diameter, left ventricular (LV) end-
diastolic (EDV), end-systolic (ESV) volume, and ejection fraction
(EF) by the modiﬁed Teichholz method with subsequent LV massdetermination fromM-modewere all measured as routine. LVmass
index (g/m2) was deﬁned as the ratio of LV mass to body surface
area (BSA). LV mass index larger than 95 gm/m2 in women and
115 gm/m2 in menwas further deﬁned as LV hypertrophy (LVH). All
parameters were assessed by M-mode from the para-sternal long-
axis view. Patients with at least signiﬁcant valvular heart disease,
pulmonary hypertension (systolic pulmonary arterial pressure
more than 65 mmHg), existence of congenital heart diseases, or LV
systolic dysfunction, were excluded from this study.
2.5. Statistical analysis
Relationships between morphologic alteration by ECG criteria
and age were assessed using Pearson’s (for continuous variables)
and point biserial (for categorical variables with two levels)
correlation coefﬁcients. The nonparametric trend test was used to
test the trend of various electrical components across different age
groups. Linear regression analysis was performed to assess the ECG
parameters inﬂuencing FRS and ATP scores; BMI and gender were
entered into FRS, and age and gender were entered into ATP score
in multivariatemodels. Logistics regression analysis was performed
to analyze the odds ratio of signiﬁcant factors associated with
patients with LVH. Variables with p< 0.05 in the univariate analysis
were selected and evaluated by multivariate regression models.
Statistical analyses were performed using SPSS 15.0 statistical
software (SPSS Inc, Chicago, IL, USA). Furthermore, a receiver
operating characteristic (ROC) curve was employed to obtain the
area under the curve (AUC) in identifying LVH by utilizing all ECG-
derived parameters STATA 8.0 (StataCorp, College Station, TX, USA).
All statistical assessments were two-sided and considered signiﬁ-
cant when p< 0.01.
3. Results
The echocardiographically deﬁned LVH geometries are shown
schematically in Fig. 1 for participants stratiﬁed by age. Among the
participants younger than 65 years of age, 71.2% (220/309) had
normal results and 23.3% (72/309) showed concentric remodeling.
Among the participants older than 65 years of age, the fractionwith
concentric remodeling was the same as that in the younger
patients, but the fractions of patients with eccentric remodeling
and concentric hypertrophy were greater, and the fraction with
normal results decreased to 45.6%.
In Table 1, we listed the baseline demographic data enrolled in
this study. With increasing age, body height tended to decrease
with increasing waist circumference, waist-to-hip ratio, systolic
blood pressure, body mass index and decreased body surface area
(trend p< 0.001) observed. There was also a trend toward higher
fasting serum glucose, total cholesterol, triglyceride and worsened
renal function (trend p< 0.001) with aging. Prevalence of hyper-
tension and diabetes history increased with age together with
lower prevalence of smoking (trend p< 0.05). Echo-derived
parameters including higher LV mass, mass index and left atrial
diameter, also increased with aging, as well as increasing estimated
cardiovascular risk scores (all p< 0.05).
The relationships between age and various ECG parameters are
shown in Table 2. The QRS axis showed a signiﬁcant negative
correlationwith age (g¼0.112, p¼ 0.031). In contrast, therewere
positive correlations between age and ECG-derived P duration,
QRS axis, QTc, ATP score, FRS, left atrial enlargement (LAE), strain
pattern, Sokolow-Lyon score, Cornell voltage (gender adjusted),
Cornell product, McPhie score, and Gubner & Ungerleider criterion
(p< 0.05).
Univariate and multivariate linear regression analyses were
performed to examine the relationship between the FRS and ECG
Fig. 1. Echocardiographically deﬁned LVH geometries among patients stratiﬁed by age. (A) Participants <65 years of age and (B) Participants 65 years of age.
Assessment of Cardiovascular-Related Risks by Surface Electrocardiography 157parameters (Table 3). For participants younger than 65 years of age,
the Sokolow-Lyon score, Cornell voltage, Cornell product, McPhie
score, and Gubner & Ungerleider criterion were found to be
signiﬁcantly associated with FRS by univariate linear regression
analysis. Multivariate analysis revealed that the Sokolow-Lyon
score, Cornell voltage, Cornell product, McPhie score, and Gubner
& Ungerleider criterion were all positively associated with the FRS,
while the McPhie score and Gubner & Ungerleider criterion were
positively associated with FRS after controlling for BMI and gender
(p< 0.05) (Table 3). Among the participants who were 65 years of
age or older, only the Cornell product was signiﬁcantly associated
with FRS by univariate analysis, and this association disappeared
after multivariate analysis.
The Gubner & Ungerleider criterion was positively associated
with ATP score after adjustment for age and gender among
participants younger than 65 years of age (p< 0.05) (Table 4).Table 1
The relationships between age, baseline demographics and estimated cardiovascular risk
Age groups <45 (n¼ 55) 45e55 (n¼ 1
Age (y) 38.2 4.7 49.3 2.8
Body height (cm) 167.5 8.7 165.1 8.2
Body weight (kg) 65.2 15.1 65.7 12
Waist (cm) 79.2 12.1 80.1 9.3
Waist-hip ratio 0.85 0.08 0.86 0.07
Body mass index (kg/m2) 23.03 4.14 24.02 3.82
Body surface area (m2) 2.81 0.29 2.73 0.27
Systolic blood pressure (mmHg) 112.5 14.5 115.5 13.1
Diastolic blood pressure (mmHg) 71.5 9.9 73.6 9.5
Heart rate (beats/min) 68.1 16 65.3 11.6
Glucose (fasting) (mg/dL) e e
Cholesterol (mg/dL) 189 33.4 191.7 31.7
Triglyceride (mg/dL) 117.1 77.4 112.5 72
HDL (mg/dL) 57.4 16.3 57.3 16
eGFR (mL/min/1.73 m2) 94 14.7 88.3 17.3
Hypertension history 1 (2%) 9 (9%)
Diabetes history (%) 0 (0%) 7 (7%)
Smoking (current) (%) 23 (43%) 28 (28%)
Echo-derived parameters
LV mass (gm) 136.4 35.9 144.1 34.5
LV mass index (gm/m2) 72.6 14.1 77.2 15.4
LA diameter (mm) 29.9 5.7 31.6 4.9
LV EF (%) 66.8 6.2 66.4 6.5
Cardiovascular risk scores
ATP score 1.03 1.23 1.07 1.23
Framingham score 2.89 6.36 1.37 3.57However, there were no signiﬁcant relationships found between
any of the ECG parameters and ATP score among participants 65
years of age or older.
The univariate logistic regression model indicated that the
following parameters were signiﬁcantly correlated with LVH among
subjects whowere younger than 65 years of age (Table 5): Sokolow-
Lyon score, Cornell product, McPhie score, Gubner & Ungerleider
criterion, Framingham score, and QRS duration (p< 0.05). Variables
with a p value <0.05 in the univariate analysis were selected and
evaluated by multivariate logistic regression models. Multivariate
logistic regression indicated that the McPhie score (OR: 1.21, 95% CI:
1.03e1.43, p¼ 0.021) and Gubner & Ungerleider criterion (OR: 1.15,
95% CI: 1.02e1.30, p¼ 0.023) were signiﬁcantly associated with the
likelihood of LVH among participants younger than 65 years of age.
However, there were no factors that predicted LVH among the
participants 65 years of age or older.scores (n¼ 379).
05) 55e65 (n¼ 149) 65 (n¼ 70) p
58.7 2.7 71 6.4 <0.001
162.4 8 159.5 8.3 <0.001
65.7 11.1 62.8 9.6 0.38
83.6 9.7 84.4 9.1 <0.001
0.89 0.07 0.91 0.08 <0.001
24.8 3.09 24.71 3.46 <0.001
2.64 0.26 2.55 0.27 <0.001
121 15.3 131.7 18.9 <0.001
74.7 9.2 74.2 8.5 0.13
65.7 11.8 67.5 15.2 0.8
e e <0.001
208.6 36.4 202 45.4 <0.001
140 87.4 135.8 77.2 <0.001
56.6 15.1 57.8 14.1 0.78
85.1 14.4 76.8 15 <0.001
17 (11%) 24 (34%) <0.001
9 (6%) 10 (14%) 0.017
22 (15%) 13 (19%) <0.001
152.9 37.6 173.9 40.1 <0.001
82.6 17.6 97.2 21.1 <0.001
34.2 16.8 34.7 5.3 <0.001
66.4 5.5 65.2 5.9 0.21
1.71 1.33 2.13 1.44 <0.001
4.98 2.68 7.96 3.21 <0.001
Table 4
ECG parameters inﬂuencing ATP score using linear regression.
Age< 65 (n¼ 309) Age 65 (n¼ 70)
Univariate Multivariate Univariate Multivariate
b (SE) b (SE) b (SE) b (SE)
Sokolow-Lyon
voltage
0.01 (0.01) e 0.01 (0.02) e
Cornell voltage 0.03 (0.01)* 0.18 (0.02)* 0.05 (0.03) e
Cornell product 0.00 (0.00)* 0.22 (0.001)* 0.01(0.01) e
McPhie score 0.02 (0.01) e 0.01 (0.02) e
Gubner &
Ungerleider
criterion
0.09 (0.02)* 0.20 (0.02)* 0.01 (0.04) e
Framingham score 0.26 (0.29) e 0.38 (0.50) e
P duration 0.03 (0.14) e 0.28 (0.32) e
P axis 0.01 (0.01) e 0.01 (0.01) e
QRS duration 0.02 (0.01)* 0.14 (0.007)* 0.01 (0.01)) e
QRS axis 0.01 (0.01) e 0.01 (0.01) e
QTc interval 0.01 (0.01) e 0.01 (0.01) e
SE¼ standard error. Multivariate model: adjustment for age and gender.
The factor is not in the ﬁnal model.
* Statistically signiﬁcant, p< 0.05.
Table 2
The relationships between age and various ECG parameters and estimated cardio-
vascular risks (both ATP and FRS) (n¼ 379).
Value Correlation
coefﬁcients
p
P duration (sec)a 1.67 0.55 0.178 0.001*
QRS duration (sec)a 87.76 12.19 0.097 0.061
P axis ()a 49.34 26.89 0.024 0.649
QRS axis ()a 44.31 37.72 0.112 0.031*
QTc (sec)a 396.59 33.31 0.136 0.008*
T axis ()a 32.84 25.87 0.079 0.125
LAE, yes, n (%)b 82 (21.6) 0.184 <0.001*
Strain pattern, yes, n (%)b 13 (3.4) 0.123 0.023*
Sokolow-Lyon voltage (mV)a 21.79 7.04 0.126 0.015*
Cornell voltage (mV.s)a 14.85 5.40 0.197 <0.001*
Cornell product (mV.s)a 1303.20 513.91 0.183 <0.001*
McPhie score (mV)a 24.47 7.18 0.176 <0.001*
Gubner & Ungerleider
criterion (mV)a
7.31 3.85 0.226 <0.001*
aPearson’s correlation coefﬁcients; and bPoint biserial correlation coefﬁcients.
ATP¼ adult treatment panel; FRS¼ Framingham risk score; LAE¼ left atrial
enlargement.
* Statistically signiﬁcant.
C.-C. Liu et al.158The ROC curve, calculated by using all ECG-based criteria in
identifying echo-deﬁned LVH for all participants whowere younger
than 65 years of age, generally gave a better AUC while compared
with those older than 65 years of age (Fig. 2), with the gender-
adjusted Cornell and Cornell Product yielding the largest AUC of
0.75 and 0.77 in participants aged less than 65 years and 0.65 and
0.64 in participants aged more than 65 years, respectively. With
appropriately selected cut-off, the sensitivities and speciﬁcities in
diagnosing LVH by utilizing Sokolow-Lyon score, gender-adjusted
Cornell voltage, McPhie score, Gubner & Ungerleider criterion and
Cornell product in subjects less than 65 years old were 64.7%,
76.5%, 70.6%, 64.7%, and 82.4%, 72.3%, 73.3%, 63%, 73.6%, and 76%,
respectively. In those agedmore than 65 years, the sensitivities and
speciﬁcities in diagnosing LVH were 47.6%, 66.7%, 57.1%, 52.4%, and
71.4% and 43.5%, 63%, 43.5%, 56.5%, and 56.5%, respectively.4. Discussion
In this study, we evaluated the relationships between various
ECG parameters, age, and estimates of cardiovascular risk and theTable 3
ECG parameters inﬂuencing Framingham score using linear regression.
Age< 65 (n¼ 309) Age 65 (n¼ 70)
Univariate Multivariate Univariate Multivariate
b (SE) b (SE) b (SE) b (SE)
Sokolow-Lyon
voltage
0.13 (0.04)* 0.11 (0.03)* 0.05 (0.05) e
Cornell voltage 0.08 (0.05) 0.18 (0.05)* 0.12 (0.07) e
Cornell product 0.01 (0.01)* 0.15 (0.001)* 0.01 (0.01)* e
McPhie score 0.19 (0.04)* 0.17 (0.04)* 0.05 (0.05) e
Gubner &
Ungerleider
criterion
0.41 (0.07)* 0.17 (0.07)* 0.09 (0.09) 0.21 (0.09)
Framingham score 1.92 (1.04). e 1.22 (1.09) e
P duration 0.62 (0.51) e 0.04 (0.73) e
P axis 0.01 (0.01) e 0.01 (0.02) e
QRS duration 0.04 (0.03) e 0.04 (0.02) e
QRS axis 0.01 (0.01) e 0.02 (0.01) 0.27 (0.009)*
QTc interval 0.01 (0.01) e 0.01 (0.01) e
SE¼ standard error.
Multivariate model: adjustment for body mass index (BMI) and gender. The factor is
not in the ﬁnal model.
* Statistically signiﬁcant, p< 0.05.different diagnostic yields among subjects of different age groups.
We further tested the usefulness and age-related differences of
surface ECG in identifying the presence of LVH determined by
echocardiography. We observed that the ECG parameters were
signiﬁcantly correlated with the participant’s age and that several
ECG parameters were positively correlated with estimated cardio-
vascular risks as assessed by FRS and ATP with and without
adjustment.
There has been much effort over the decades on developing
tools to assess the risk for CHD in the asymptomatic population.
Because of the complexity of CHD and its multiple causes, it is now
generally accepted that an algorithm for accurately predicting the
presence of CHD will comprise multiple parameters. The FRS,
which incorporates risk factors determined during the Framingham
study, was one of the ﬁrst such algorithms1. The ATP III score
developed by the NCEP III, extended the Framingham parameters
by including family history, diabetes, and metabolic syndrome and
deﬁning the risk in terms of 3 categories on the basis of the prob-
ability of experiencing a cardiac event over a 10 year period2. The
FRS and the NCEP III recommendations are still considered to be
very useful in assessing cardiovascular risk in asymptomatic indi-
viduals15. ECG remains one of the most widely available and least
expensive diagnostic tools potentially appropriate for screening
large populations for cardiovascular disease. A unique aspect of our
study was that we examined the association of the ECG parameters
with the two major tools, the FRS and ATP scores, for estimating
cardiovascular risk. Among the younger participants, multivariate
linear regression analysis showed that several ECG parameters were
all positively, signiﬁcantly associatedwith FRS and ATP scores which
remained statistically signiﬁcant after multivariate adjustment.
Numerous investigators have attempted to identify criteria for
ECG diagnosis of LVH12,16e18. The various criteria are highly
speciﬁc for LVH but are limited by low sensitivity. In comparison
with echocardiography, which found a 20% prevalence of LVH in
the Framingham Heart Study19, ECG found a prevalence of only
2%16. Echocardiographic analysis is an excellent tool for deter-
mining the mass and shape of the heart, and because LV mass has
become the “gold standard” clinical measure of LVH20, most
evaluations of the diagnostic performance of ECG have measured
it against echocardiography. The four ECG parameters in our study
that were associated with the FRS among the younger group of
participants were also associated with the presence of LVH after
univariate analysis. However, only the McPhie score and the
Fig. 2. ROC curve for predicting LVH in participants who were younger or older than 65 years of age.
Table 5
ECG parameters in predicting LVH.
Age< 65 (n¼ 309) Age 65 (n¼ 70)
Univariate Multivariate Univariate Multivariate
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Sokolow-Lyon voltage 1.10 (1.04e1.06)* 0.91 (0.78e1.06) 0.99 (0.90e1.07) e
Cornell voltage 1.06 (0.98e1.15) e 1.01 (0.90e1.13) e
Cornell product 1.00 (1.00e.01)* 1.00 (0.99e1.00) 1.00 (0.99e1.01) e
McPhie score 1.13 (1.07e1.20)* 1.21 (1.03e1.43)* 0.99 (0.92e1.08) e
Gubner & Ungerleider criterion 1.46 (1.08e1.99)* 1.15 (1.02e1.30)* 1.18 (0.77e1.83) e
Framingham score 5.96 (2.07e17.17)* 1.11 (0.19e6.62) 2.14 (0.51e6.52) e
P duration 1.57 (0.74e3.33) e 2.34 (0.69e7.93) e
P axis 0.99 (0.98e1.01) e 0.99 (0.96e1.02) e
QRS duration 1.04 (1.00e1.07)* 1.04 (0.99e1.08) 1.02 (0.99e1.06) e
QRS axis 0.99 (0.98e1.04) e 1.01 (1.00e1.03) e
QTc interval 0.99 (0.98e1.00) e 1.01 (0.99e1.03) e
OR¼ odds ratio. Multivariate model: adjustment for gender and creatinine (mg/dL).
The factor is not in the ﬁnal model.
* Statistically signiﬁcant, p< 0.05.
Assessment of Cardiovascular-Related Risks by Surface Electrocardiography 159Gubner & Ungerleider criterion remained signiﬁcant predictors of
the presence of LVH after multivariate analysis.
The individual ECG criteria that have been evaluated in previous
reports13,17,21, have demonstrated speciﬁcities in the range of 90% to
97%, whereas sensitivities have been signiﬁcantly lower, ranging
from 3.8% to a maximum of 38% in patients with less severe
hypertrophy (LV mass index [LVMI] 152.8 g/m2 to 62% in patients
with LVMI> 152.8 g/m2). Whether parameters can be identiﬁed
that will allow ECG to substitute for echocardiography as a screening
tool is an unlikely20. Nevertheless, the use of ECG voltage criteria can
be a valuable tool to assist in the challenge of diagnosing CHD in
asymptomatic individuals. The use of ECG voltage criteria has
recently been successfully extended to the detection of disorders
such as hypertrophic cardiomyopathy in young people22. In this
application, the reported positive predictive value (PPV) and nega-
tive predictive value (NPV) for the Gubner & Ungerleider criterion
were 100% and 93%, respectively, and combination with the Cornell
voltage improved the NPV. Kohsaka et al. demonstrated that the
Cornell voltage criterionwas a predictor of ischemic stroke and that,
when combined with echocardiographic analysis, it was associated
with a 3.5-fold increase in risk for stroke23. Morin et al have shown
that QRS duration predicted sudden cardiac death in patients with
hypertension24. A study by Palmieri et al has revealed an association
of ECG characteristics and metabolic risk factors with inappropri-
ately high LV mass in patients with LVH25. In our study, several ECG
parameters were helpful and yielded useful diagnostic accuracy in
identifying LVH in the younger rather than the older population.
Furthermore, our data revealed that even in a relatively healthy
population free from known cardiovascular diseases, the electrical
remodeling patterns in terms of various surface ECG parameters
were observed to parallel with the aging process. In our data, severalspeciﬁc ECG features were associated with age and were indepen-
dently coincident with clinical factors relating to higher cardiovas-
cular risks. Parameters, especially the McPhie score and Gubner &
Ungerleider criterion, identiﬁed ventricular hypertrophy well in
subjects less than 65 years old. Similar to the previous ﬁndings in
our study, various ECG parameters seemed to be less reliable in
identifying both cardiovascular risks in the elderly population. The
reasons can be 2efold. As the ventricular remodeling process,
assessed by various surface ECG parameters, may actually denote
ventricular hypertrophy in terms of extremely increased LV mass,
recent studies indicated that themain cardiac phenotype alterations
relating to various cardiovascular risk factors in elderly subjectsmay
actually involve concentric remodeling26. Such concentric remod-
eling processes and alterations may not necessarily be characterized
by surface ECG parameters. Furthermore, the potential selection bias
in this study may also help to explain this ﬁnding. As a hypertro-
phied heart structure and higher cardiovascular risk score reﬂecting
underlying metabolic derangements may denote supplemental
pathways into higher cardiovascular risks, subjects carrying on both
features may theoretically experience higher events and less
possibly survive longer, which may thus attenuate the correlation
between each other in the elderly population26.
5. Conclusion
We have shown that electrical alterations, as determined by the
Gubner & Ungerleider criteria and McPhie scores obtained from
12-lead surface ECG, were correlated with age and estimated
cardiovascular risk factors. Furthermore, Cornell Product and
gender-adjusted Cornell criteria further identiﬁed well the
ventricular structural changes associated with LVH in the younger
C.-C. Liu et al.160population. However, surface ECG may be less reliable in the older
population. Our results suggested that quantitative electrocardi-
ography may be clinically feasible and they were highly associated
with several cardiovascular risk surrogates.
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